Publications scientifiques

*Lapointe, E., Deacon, C., *Royer-Perron, L., Cunnane, S. C., Castellano, C.-A., & Bocti, C. (2016). Temporal lobe atrophy may be underrecognized in older patients with new-onset epilepsy. Canadian Journal of Neurological Sciences, 43(5), 731-734.

*Croteau, É., Castellano, C.-A., Bocti, C., Fülöp, T., Paquet, N., & Cunnane, S. C. (6 mai 2016). Étude du métabolisme énergétique cérébral chez les personnes avec un trouble léger de la cognition ou diagnostiqué Alzheimer. 12^e Journée scientifique du CDRV et 26^e Édition du Gérontoclub. Sherbrooke, Québec, Canada. p. 17.

Lapointe, E., Deacon, C., Bocti, C., Royer-Perron, L., Cunnane, S. C., & Castellano, C.-A. (2016, September 30 - October 3). Temporal lobe atrophy: frequent in eldery with epilepsy of unknown etiology. 15^th European Congress on Clinical Neurophysiology. Brno, Czech Republic. Clinical Physiology, 127(4), e161.

*Croteau, É., Castellano, C.-A., Fortier, M., Bocti, C., Fülöp, T., Paquet, N., & Cunnane, S. C. (2016, September 20-24). Brain glucose and ketone metabolism in mild cognitive impairment and Alzheimer's disease: a cross-sectional study. 5^th Symposium on Ketogenic Therapies. Banff, Alberta, Canada.

*Croteau, É., Castellano, C.-A., Fortier, M., Bocti, C., Fülöp, T., Paquet, N., & Cunnane, S. C. (2016, September 20-24). Brain ketone uptake responds normally to increased plasma ketone availability in Alzheimer's disease: preliminary results. 5^th Symposium on Ketogenic Therapies. Banff, Alberta, Canada.

Fortier, M., Baril, O., Brodeur-Dubreuil, C., Langlois, F., Morin, M.-C., Castellano, C.-A., & al. (Bocti, C., Fülöp, T., Cunnane, S. C.) (2016, September 5-9). Proof-of-concept clinical trials assessing the effect of medium chain triglycerides (MCT) on brain energy metabolism in mild cognitive impairment (MCI) and Alzheimer's disease (AD). 12^th Congress of the International Society for the Study of Fatty Acids and Lipids. Stellenbosch, South Africa.

Castellano, C.-A., Paquet, N., Dionne, I. J., Imbeault, H., *Croteau, É., *St-Pierre, V., *Vandenberghe, C., Fortier, M., Bocti, C., Fülöp, T., & Cunnane, S. C. (2016, October 19-20). Benefits of a 3-month walking program for brain energy metabolism and cognition in mild Alzheimer's disease: preliminary results of a PET-MRI pilot study. 2^nd Edition of the International Symposium « Biology of aging: paving the way for healthy aging ». Montreal, Quebec, Canada. p. 6.

Nene, S., Charbonneau, M.-È., Fontaine, A.-C., Martel, V., Langlois, F., & Bocti, C. (2016, October 20-22). Neuropsychological test performance in patients with normal Montreal Cognitive Assessment (MoCA) scores. 45^th Annual Scientific and Educational Meeting of the Canadian Association of Gerontology. « Fostering Innovation in Research on Aging ». Montreal, Quebec, Canada.

Castellano, C.-A., Paquet, N., Dionne, I. J., Imbeault, H., Langlois, F., *Croteau, É., Fortier, M., Lacombe, G., Bocti, C., & Cunnane, S. C. (2-4 novembre 2016). Bénéfices potentiels de la pratique de la marche chez des patients Alzheimer : résultats préliminaires en neuroimagerie. 3^e Congrès québécois sur la maladie d'Alzheimer et les maladies apparentées. Sherbrooke, Québec, Canada. Prix Serge Gauthier.

Morin, M.-C., Brodeur-Dubreuil, C., Baril, O., Lambert, L.-A., Fortier, M., Castellano, C.-A., Fülöp, T., Bocti, C., Tessier, D., Lacombe, G., Lorrain, D., & Cunnane, S. C. (2-4 novembre 2016). Le recrutement des participants avec un trouble cognitif en région : défis et solutions. 3^e Congrès québécois sur la maladie d'Alzheimer et les maladies apparentées. Sherbrooke, Québec, Canada.